"Our care team at Assarian Cancer Center in Novi, Michigan, delivers personalized care for your needs. Our Ascension Michigan cancer care doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists and our cancer care team is dedicated to helping you defeat cancer."

During the past decade, Assarian Cancer Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Assarian Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Assarian Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Assarian Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Assarian Cancer Center" in a lesser frequency.

Most popular intervention types in "Assarian Cancer Center" are "Other" (10 trials), "Drug" (9 trials), "Biological" (5 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "FGFR Inhibitor AZD4547" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Assarian Cancer Center" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Assarian Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Assarian Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Assarian Cancer Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".